Market Gains, Nordstrom Deal, Trump's Team, Zepbound Shortage Ends

  • 📰 NBCDFW
  • ⏱ Reading Time:
  • 57 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 43%
  • Publisher: 63%

Business News

STOCK MARKET,NORDSTROM,DONALD TRUMP

The Dow Jones Industrial Average saw modest gains, while Nordstrom finalized a deal to go private. Donald Trump continues to shape his team, and the shortage of Eli Lilly's weight loss drug Zepbound has ended.

Streaming 24/7: Watch NBC 5 local news and weather for free wherever you areDow Jones Industrial Average

, meanwhile, had a smaller gain, adding just 66.69 points higher, or 0.16%. Trading was light Monday, which is expected to continue today. The market will close at 1 p.m. for the Christmas Eve holiday. Followworth roughly $6.25 billion from members of the founding Nordstrom family and the Mexican department store El Puerto de Liverpool. The family will have majority ownership of the private company, with 50.1%, while Liverpool will own 49.9%. Common shareholders, meanwhile, will receive $24.

The FDA said tirzepatide, the main ingredient in Eli Lilly's weight loss drug Zepbound, is no longer in shortage. That means patients will likely be unable to access compounded — or cheaper, off-brand — versions of the drug that compounding pharmacies were legally allowed to make during the shortage. Six patients told CNBC that they're worried about the price of the brand-name medicine.

5 ‘very profitable' side hustles to make extra cash during the holidays—one pays up to $700 for two hours of work I interviewed over 100 parents and top researchers: The No. 1 key takeaway about raising resilient kids

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 288. in BUSİNESS
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Business Business Latest News, Business Business Headlines